THE NATIONAL Institutes of Health and National Science Foundation have long been crown jewels of our nation’s biomedical research effort. Since their establishment – the NIH in the waning days of World War II and the NSF during the dawn of the Cold War – both institutions have been a source of imagination, leadership, and funding for the very basic research conducted by scientists within government labs and throughout universities across America.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.